Inventor · disambiguated record
Orrin Devinsky
Also filed as: DEVINSKY ORRIN
29 granted patents·14 pending applications·1,162 citations·filing 2005–2025
98Inventor score
Files withGW RES LTD21GW PHARMA LTD11JAZZ PHARMACEUTICALS RESEARCH UK LTD3UNIV NEW YORK3BROAD INST INC1
Top patents by PatentIndex Score
43 records- 0198US12427160B2Use of cannabinoids in the treatment of epilepsyJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2025·Granted Sep 30, 2025·1 cites·29 claims
- 0298US12064399B2Use of cannabinoids in the treatment of epilepsyJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2022·Granted Aug 20, 2024·14 cites·28 claims
- 0398US11963937B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2023·Granted Apr 23, 2024·14 cites·29 claims
- 0498US11766411B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2022·Granted Sep 26, 2023·17 cites·26 claims
- 0598US11701330B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Jul 18, 2023·19 cites·30 claims
- 0698US11633369B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2022·Granted Apr 25, 2023·26 cites·32 claims
- 0798US11446258B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Sep 20, 2022·30 cites·29 claims
- 0898US11357741B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Granted Jun 14, 2022·33 cites·28 claims
- 0998US11311498B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Apr 26, 2022·34 cites·21 claims
- 1098US11154517B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Oct 26, 2021·38 cites·26 claims
- 1198US11154516B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Granted Oct 26, 2021·42 cites·30 claims
- 1298US11096905B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Aug 24, 2021·43 cites·33 claims
- 1398US10966939B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Granted Apr 6, 2021·47 cites·21 claims
- 1498US10849860B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2018·Granted Dec 1, 2020·49 cites·32 claims
- 1598US10765643B2Use of cannabidiol in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Sep 8, 2020·35 cites·15 claims
- 1698US10709671B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2016·Granted Jul 14, 2020·52 cites·24 claims
- 1798US10709674B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2019·Granted Jul 14, 2020·50 cites·20 claims
- 1898US10603288B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2018·Granted Mar 31, 2020·49 cites·28 claims
- 1998US10137095B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted Nov 27, 2018·63 cites·8 claims
- 2098US10111840B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Oct 30, 2018·67 cites·14 claims
- 2198US10092525B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted Oct 9, 2018·62 cites·8 claims
- 2298US9956185B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·71 cites·11 claims
- 2398US9956186B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·68 cites·11 claims
- 2498US9956183B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·69 cites·18 claims
- 2598US9956184B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·67 cites·12 claims
- 2698US9949937B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted Apr 24, 2018·64 cites·14 claims
- 2797US12318356B2Use of cannabinoids in the treatment of epilepsyJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2023·Granted Jun 3, 2025·2 cites·26 claims
- 2891US2024165048A1Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2023·Application pending·0 cites
- 2991US2025345349A1Cannabinoids in the treatment of epilepsyJAZZ PHARMACEUTICAL RES UK LIMITED·Filed 2025·Application pending·0 cites
- 3084US2022202738A1Cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2022·Application pending·0 cites
- 3184US2024350428A1Use of cannabinoids in the treatment of epilepsyJAZZ PHARMACEUTICALS RESEACH UK LTD·Filed 2024·Application pending·0 cites
- 3280US7885706B2System and device for seizure detectionUNIV NEW YORK·Filed 2006·Granted Feb 8, 2011·36 cites·22 claims
- 3380US2024261234A1Use of cannabidiol in the treatment of nocturnal snoringGW RES LTD·Filed 2023·Application pending·0 cites
- 3477US2020368179A1Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Application pending·0 cites
- 3575US2020179303A1Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Application pending·0 cites
- 3673US2023032502A1Use of cannabidiol in the treatment of nocturnal snoringGW RES LTD·Filed 2022·Application pending·0 cites
- 3763US2023069642A1Precise template-free correction of brca1 mutation in human cells via genome editingUNIV NEW YORK·Filed 2022·Application pending·0 cites
- 3861US2021330636A1Use of cannabidiol in the treatment of epilepsyGW RES LTD·Filed 2020·Application pending·0 cites
- 3949US2017239193A1Use of cannabidiol in the treatment of nocturnal snoringGW PHARMA LTD·Filed 2015·Application pending·0 cites
- 4046US2022370805A1Electroencephalography (eeg) electrode arrays and related methods of useUNIV DUKE·Filed 2020·Application pending·0 cites
- 4146US2018355432A1Identification of epilepsy patients at increased risk from sudden unexpected death in epilepsyUNIV NEW YORK·Filed 2016·Application pending·0 cites
- 4244US2022195457A1Interneuron-specific therapeutics for normalizing neuronal cell excitability and treating dravet syndromeBROAD INST INC·Filed 2020·Application pending·0 cites
- 4337US9042974B2Apparatus and method for monitoring and treatment of brain disordersLUDVIG NANDOR·Filed 2005·Granted May 26, 2015·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Orrin Devinsky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →